TR-701: Phase I started

Trius began a double-blind, single- and multiple-ascending dose, U.S. Phase I trial in 88 healthy volunteers to compare oral TR-701 vs. Zyvox linezolid from Pfizer Inc. (NYSE:PFE, New York, N.Y.). T...